
    
      To determine the safety, tolerability, and maximum tolerated dose (MTD) of MEDI 547 in a dose
      escalation cohort for either administration schedule 1 dose every 3 weeks or 1 dose every
      week in adult subjects with relapsed or refractory solid tumors.
    
  